BioSpace News Archive

Advanced Healthcare IT AI Solution Can Speed Up Clinical Response and Help Increase Diagnostic Confidence to Take Patient Care to the Next Level

BOSTON, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that clinical data from the ongoing IMR-687 Phase 2a open label extension (OLE) clinical trial in adult patients with sickle cell disease (SCD) will be presented at the 62 nd American Society of Hematology (ASH) Annual M

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announces publication of AUTO6 (1RG-CAR T) Phase 1 data in Science Translational Medicine.

Carestream Health showcased its expertise in medical imaging across an array of clinical specialties at the virtual meeting of the Radiological Society of North America.

UK diagnostics firm Salient Bio has announced the commercial roll out of its robotics driven COVID-19 mass testing platform.

The company spotlights Computed Tomography and Artificial Intelligence Technology, as well as its recently opened U.S. factory and showroom.

Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Piper Sandler Virtual Healthcare Conference on Wednesday, December 2, 2020 at 3:30 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is a globa

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced the completion of a Boston Analytical study “Silicone Disk Method for In Vitro Assessment of Antimicrobial Activity Against Resistant Staphylococcal Biofilms by Minocycline-EDTA-Ethanol and EDTA-Ethanol Lock Solutions.”

Therapix Biosciences Ltd. (OTC Pink: TRPXY) (the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based pharmaceuticals, today released a letter to its shareholders from its Chief Executive Officer, Mr. Amitay Weiss.

Ortho Clinical Diagnostics announced the CE Mark availability of the semi-automated ORTHO Optix™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected of an automated platform.